Risk factors for distant metastases in head and neck squamous cell carcinoma
- PMID: 16847186
- DOI: 10.1001/archotol.132.7.762
Risk factors for distant metastases in head and neck squamous cell carcinoma
Abstract
Objectives: To evaluate the frequency of distant metastases (DM) and to determine the ability of certain clinical and pathologic factors to predict the development of distant metastases.
Design: Retrospective analysis.
Setting: University hospital.
Patients: A total of 1972 patients with oral, oropharyngeal, hypopharyngeal, and laryngeal squamous cell carcinomas who were treated from 1981 to 1998 and who were not diagnosed as having DM at the time of initial treatment.
Main outcome measures: We evaluated the frequency of DM and the influence of different variables in their appearance.
Results: A total of 181 patients (9.2%) (95% confidence interval, 7.9%-10.5%) developed DM. Younger age (<45 years), hypopharyngeal localization, an advanced T stage and/or N stage tumor according to the TNM staging system, high histologic grade, and locoregional control were found to be significantly associated with the risk of DM at both univariate and multivariate analyses.
Conclusions: The incidence of DM in subjects with head and neck squamous cell carcinoma is relatively low. The risk of DM is influenced by age, site of primary cancer, local and/or regional extension, grading, and achievement of locoregional control.
Similar articles
-
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028. Laryngoscope. 2001. PMID: 11404625
-
Bilateral neck node metastasis: a predictor of isolated distant metastasis in patients with oral and oropharyngeal squamous cell carcinoma after primary curative surgery.Laryngoscope. 2007 Sep;117(9):1576-80. doi: 10.1097/MLG.0b013e318093ee2b. Laryngoscope. 2007. PMID: 17667136
-
[Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].Zhonghua Er Bi Yan Hou Ke Za Zhi. 2004 Mar;39(3):171-5. Zhonghua Er Bi Yan Hou Ke Za Zhi. 2004. PMID: 15283298 Chinese.
-
[Distant metastases originating from tumors of the larynx and hypopharynx].Rev Laryngol Otol Rhinol (Bord). 1989;110(3):267-71. Rev Laryngol Otol Rhinol (Bord). 1989. PMID: 8638048 Review. French.
-
Oral maxillary squamous cell carcinoma: management of the clinically negative neck.J Oral Maxillofac Surg. 2008 Apr;66(4):762-6. doi: 10.1016/j.joms.2007.12.017. J Oral Maxillofac Surg. 2008. PMID: 18355602 Review.
Cited by
-
Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer.Genome Med. 2023 Nov 17;15(1):98. doi: 10.1186/s13073-023-01236-w. Genome Med. 2023. PMID: 37978395 Free PMC article.
-
Brachytherapy Approach Using 177Lu Conjugated Gold Nanostars and Evaluation of Biodistribution, Tumor Retention, Dosimetry and Therapeutic Efficacy in Head and Neck Tumor Model.Pharmaceutics. 2021 Nov 9;13(11):1903. doi: 10.3390/pharmaceutics13111903. Pharmaceutics. 2021. PMID: 34834318 Free PMC article.
-
Hypoxia-Induced Long Noncoding RNA HIF1A-AS2 Regulates Stability of MHC Class I Protein in Head and Neck Cancer.Cancer Immunol Res. 2024 Oct 1;12(10):1468-1484. doi: 10.1158/2326-6066.CIR-23-0622. Cancer Immunol Res. 2024. PMID: 38920249 Free PMC article.
-
Molecular diagnosis of minimal residual disease in head and neck cancer patients.Cell Oncol (Dordr). 2012 Oct;35(5):367-75. doi: 10.1007/s13402-012-0097-1. Epub 2012 Sep 4. Cell Oncol (Dordr). 2012. PMID: 22945509
-
Multiple Regression Analysis of Predictors of Bone Scintigraphy Positivity in Patients with Head and Neck Cancers.Nucl Med Mol Imaging. 2018 Feb;52(1):62-68. doi: 10.1007/s13139-017-0492-7. Epub 2017 Aug 29. Nucl Med Mol Imaging. 2018. PMID: 29391914 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical